CDC Newsroom · May 20, 2026
Transcript - Update on Ebola Outbreak in the Democratic Republic of the Congo and Uganda, 5/20/2026
Transcript - Update on Ebola Outbreak in the Democratic Republic of the Congo and Uganda, 5/20/2026
Latest medical news · page 57
The latest headlines across every section, pulled from official and open-access sources.
MedlinePlus (NLM) · May 20, 2026
How Monkeypox Spreads
Source: Centers for Disease Control and Prevention Related MedlinePlus Pages: Mpox
WHO · May 20, 2026
Seventy-ninth World Health Assembly – Daily update: 19 May 2026
Summary of discussions of 19 May at Seventy-ninth World Health Assembly
JAMA Clinical Reviews · May 20, 2026
Diet and Exercise Recommendations for Patients Taking GLP-1 Receptor Agonists
The GLP-1 receptor agonists reduce appetite and greatly facilitate weight loss. Robert Kushner, MD, of Northwestern University Feinberg School of Medicine joins JAMA Deputy Editor Mary M. McDermott, MD, to discuss appropriate diet and exercise recommendations for patients receiving GLP-1 receptor agonists for weight loss. Related Content: Lifestyle Modification and Incretin-Based Therapy for Obesity The Conundrum of Exercise for Weight Management in the GLP-1 Receptor Agonist Era
PLOS Medicine · May 20, 2026
Prescribed hormonal contraceptive use trends in the Estonian Biobank: A longitudinal observational study
by Jelisaveta Džigurski, Märt Möls, Kristi Läll, Hannah Currant, Mall Eltermaa, Estonian Biobank Research Team , Reedik Mägi, Lili Milani, Triin Laisk Background Hormonal contraceptives (HCs) are widely used and have well-documented population-level statistics. Previous studies with short follow-ups have focussed on individual HC use and side effects. However, the same aspects over longer periods, HC formulation switching, and the impact of genetic factors on HC side effects remain understudied due to the limited availability of suitable datasets. We investigated whether the Estonian Biobank…
PLOS Medicine · May 20, 2026
Brain morphology in Anorexia Nervosa and its subtypes: A multi-cohort study of individual participant data
by Fabio Bernardoni, Dominic Arold, Luis Schoppik, Klaas Bahnsen, Ruiyang Ge, Clara Moreau, Lasse Bang, Federico D’Agata, Giovanni Abbate-Daga, Christian K. Tamnes, Iain Campbell, Owen O’Daly, Ulrike Schmidt, Guido Frank, Stefanie Horndasch, Andreas Hess, Arnd Dörfler, Hans-Christoph Friederich, Joe Simon, Angela Favaro, Luca Lavagnino, Christina E. Wierenga, Amanda Bischoff-Grethe, Amy E. Miles, Allan Kaplan, Aristotle Voineskos, Paul A. M. Smeets, Annemarie A. van Elburg, Unna Danner, Sophia I. Thomopoulos, Laura Berner, Neda Jahanshad, Sophia Frangou, Joseph A. King, Paul Thompson, Stefan…
PLOS Medicine · May 20, 2026
Associations between hematologic dynamics during pregnancy and obstetric complications: A retrospective observational study
by Veronica Tozzo, Rachel Petherbridge, Kaitlyn James, Sarah Hsu, Deepti Pant, Chloe Michalopoulos, Brody H. Foy, Tanayott Thaweethai, Christopher Mow, Jacqueline Maya, Carolina Batlle Camero, Lydia Shook, Kathryn J. Gray, Logan Mauney, John M. Higgins, Camille E. Powe Background Pregnancy alters hematologic state as measured by complete blood count (CBC), but the longitudinal changes in CBC indices that define healthy pregnancies are not well established. In a large cohort based at an academic health system in the United States, we aimed to define reference intervals and typical longitudinal…
FDA Newsroom · May 20, 2026
FDA Warns Retailers Selling Illegal Tobacco Products That Look Like Everyday Products
FDA Warns Retailers Selling Illegal Tobacco Products That Look Like Everyday Products
FDA Enforcement · May 20, 2026
Drug recall: Oasis Tears PF, Preservative-Free Lubricant Eye Drops, 10mL/0.34 Fl OZ Bottle, Sterile, Manufactured for:…
Lack of Assurance of Sterility: The recall is being initiated out of an abundance of caution following FDA observations noted during a recent inspection of Excelvision. — Oasis Medical, Inc. · Class II · Ongoing
FDA Enforcement · May 20, 2026
Drug recall: Buprenorphine Hydrochloride, Injection, 0.3mg/mL, 5x1 mL Single Dose Vials, Rx only, Manufactured for:…
Presence of particulate matter: identified as Buprenorphine free base — ENDO USA, Inc. · Class II · Ongoing
FDA Enforcement · May 20, 2026
Drug recall: Ascend Laboratories, LLC, Metoprolol Succinate Extended-Release Tablets, USP, 25 mg* Rx Only, Manufactured…
Failed Dissolution Specifications — Ascend Laboratories, LLC · Class II · Ongoing
FDA Enforcement · May 20, 2026
Device recall: Medline medical convenience kits, containing Namic Manifold, Labeled as: HEART CATH PACK-LF, Medline Kit…
Medline has identified the presence of particulate within the fluid path of the Manifolds. — Medline Industries, LP · Class I · Ongoing
FDA Enforcement · May 20, 2026
Device recall: Revolution CT ES, X-ray Computed Tomography, Model Number 5590000-15
GE HealthCare has become aware of a potential security vulnerability impacting AW Server deployed via Edison Health Link (EHL) based CT Smart Subscription used in conjunction with certain Revolution Apex, Revolution Ascend, and Revolution CT systems. — GE Medical Systems, LLC · Class II · Ongoing
FDA Enforcement · May 20, 2026
Device recall: BARD Dynamic Tip Steerable, Product Number 6DYNTP001;
Incomplete seals on sterile product — Stryker Sustainability Solutions · Class II · Ongoing
FDA Enforcement · May 20, 2026
Device recall: LVIS Intraluminal Support Device, REF/Outside Diameter(OD)xTotal Length(TL)xWorking Length(WL):…
Stent-assisted coiling device may due to commingling during manufacturing have dimensional nonconformance and/or incorrect device configuration. If device is oversized may lead to increased vessel wall stress, neointimal hyperplasia, vessel injury/rupture; if undersized may lead to incomplete expansion/malposition, acute stent thrombosis, distal embolizat… — MICROVENTION INC. · Class II · Ongoing
FDA Enforcement · May 20, 2026
Device recall: Brand Name: DONJOY Product Name: ICEMAN W/,UNIV,LOOP,NS,EH Model/Catalog Number: 11-1424 Software Version:…
Due to broken connector which may result in a temporary interruption of prescribed cold therapy. — DJO, LLC · Class II · Ongoing
FDA Enforcement · May 20, 2026
Device recall: BARD Dynamic Deca Steerable, Product Number 201101; REPROCESSED ELECTROPHYSIOLOGY CATHETER
Incomplete seals on sterile product — Stryker Sustainability Solutions · Class II · Ongoing
FDA Enforcement · May 20, 2026
Device recall: SELENIA DIMENSIONS MAMMOGRAPHY SYSTEMS. Model Numbers: SDA-SYS-3000-2D-HTC, SDA-SYS-3000-3D,…
Complaints have been received of systems developing loose, missing, or broken internal bolts over time. — Hologic, Inc · Class II · Ongoing
FDA Enforcement · May 20, 2026
Device recall: Rolls of label stock used with the Omnicell i.v.Station. 1. Part Number 258920028, LABEL, STERILE,…
Potential for mislabeled syringe produced by the i.v.STATION device. — Omnicell, Inc. · Class I · Ongoing
FDA Enforcement · May 20, 2026
Device recall: Daig Livewire Steerable, Product Number 401904; REPROCESSED ELECTROPHYSIOLOGY CATHETER
Incomplete seals on sterile product — Stryker Sustainability Solutions · Class II · Ongoing
FDA Enforcement · May 20, 2026
Device recall: Revolution Ascend, computed tomography, Model Numbers 6969000-100 and 6969000-300
GE HealthCare has become aware of a potential security vulnerability impacting AW Server deployed via Edison Health Link (EHL) based CT Smart Subscription used in conjunction with certain Revolution Apex, Revolution Ascend, and Revolution CT systems. — GE Medical Systems, LLC · Class II · Ongoing
FDA Enforcement · May 20, 2026
Device recall: Namic Preceptor Manifold, custom, Medline Product Number/SKU 64037107; Extravascular blood pressure transducer
Medline has identified the presence of particulate within the fluid path of the Manifolds. — Medline Industries, LP · Class I · Ongoing
FDA Enforcement · May 20, 2026
Device recall: Medline medical convenience kits, containing Namic Manifold, Labeled as: TAVI, Medline Kit Number/SKU…
Medline has identified the presence of particulate within the fluid path of the Manifolds. — Medline Industries, LP · Class I · Ongoing
FDA Enforcement · May 20, 2026
Device recall: Medtronic SynchroMed Flex Infusion Mode - A810 Clinician Programmer Software Application, loaded on the…
Software issue: When programming the SynchroMed Pump with the A810 CP App in Flex Infusion Mode, the infusion steps should automatically be arranged in consecutive order, from earliest to latest. However, in rare cases, the steps may be displayed out of order. If this occurs, the programmed Flex Infusion schedule will not be delivered at the intended time… — Medtronic Neuromodulation · Class II · Ongoing